Press Releases


The Opiate MBR: What They Are Saying

Ohio State Medical Association: “Senate Bill 319 is one more step in the right direction as we continue our efforts to address prescription drug abuse and misuse in Ohio.”

Ohio Association of County Behavioral Health Authorities: “We applaud the Ohio General Assembly and the Administration for the passage of the Opiate MBR (Senate Bill 319) and the continued emphasis on fighting Ohio’s opiate epidemic. By working to expand access to naloxone, ensuring the availability of quality treatment services and recovery supports, and working to prevent the misuse and abuse of prescription medicines, Ohio continues to make progress to address issues related to opiate abuse.”

Ohio Council of Behavioral Health & Family Services Providers: “We are grateful to Governor Kasich and the Ohio General Assembly for their continued efforts to create an environment that supports the prevention, treatment, and recovery from addiction.  The passage of Senate Bill 319 expands access to overdose reversal drugs, improves prescribing practices, and increases access to counseling and medications for underserved communities and pregnant women throughout Ohio.”

Ohio Community Corrections Association: "Thanks to the joint leadership of Governor Kasich, Director Plouck, Senator Eklund and the Pharmacy Board, we are moving in the right direction in assisting Ohio citizens including those in community corrections to prevent opiate overdose deaths."

Ohio Dental Association: “Because of the steps being taken by Ohio’s policymakers and interested parties, including prescribers, real progress is being made in addressing the drug abuse and addiction crisis in Ohio.”

Coalition on Homelessness & Housing in Ohio: “COHHIO is pleased to see Ohio take additional steps to address the opiate epidemic through the passage of Senate Bill 319 which builds on other progress to date.”

Ernie Boyd, Executive Director, Ohio Pharmacists Association: “Over the years, we have learned that in order to turn the back the tide of drug abuse in Ohio communities, there must be a greater focus on reasonable restrictions on drugs with high abuse potential, better tracking of controlled substances, greater accountability within the health care professions, increased access to life-saving medications, and enhanced treatment options for patients. We are pleased to see that these comprehensive approaches touch all of those bases, without creating excessive burdens on the provider communities.”

Christopher Jerry, President & CEO, The Emily Jerry Foundation: “Senate Bill 319 greatly enhances the Board of Pharmacy’s oversight of pharmacy technicians.  This is an important step towards improving patient safety and reducing diversion at the pharmacy.  I applaud the work of the Governor and the Board of Pharmacy in their efforts to safeguard the citizens of Ohio.”

Phil Nunes, Chief Programs Officer, Alvis, Inc.: “The passage of Senate Bill 319 means facilities like Alvis will have improved access to naloxone and will be equipped to effectively respond to an overdose emergency.  Expanding access to naloxone in settings that serve at-risk individuals has the potential to save untold lives.  I commend the work of Governor John Kasich, Senator John Eklund, the State of Ohio Pharmacy Board and the Ohio General Assembly for increasing the availability of this important medication.”

John L. Edwards, Sr., Executive Director, Urban Minority Alcoholism and Drug Abuse Outreach Program of Lucas County: “The MBR reforms will continue to build upon progress that our organization, and similar organizations throughout the state of Ohio, have experienced to date.”

Larry Moliterno, President, Ohio Alliance of Recovery Providers: “This legislation gives families, providers and communities more tools to help treat addiction and stop overdose deaths by increasing access to Naloxone and ensuring high quality standards for all treatment providers.”

Jennifer Moses, CEO, Zepf Center: “These reforms targeting opiate addiction demonstrate the Administration’s dedication to fighting this epidemic and will improve the treatment system as a whole.”